DS

Dharmendra Singh

Active Director Director DIN 08045792
DIN 08045792 First appointment Feb 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2019
Shareholding value •••• Premium profile

About Dharmendra Singh

Data last updated:

Dharmendra Singh is a Director at Orb Pharma Private Limited (since 2019). The company operates in Pharma. Orb Pharma Private Limited reported revenue of ₹1.32 Cr (FY 2025).

DIN 08045792
Primary Designation Director
Industry Pharma
First Appointment 28 Feb 2019
Oldest Company Age 20 yrs
Largest company Orb Pharma Private Limited · ₹1.32 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Orb Pharma Private Limited U24232DL2006PTC146702
Director28 Feb 20192006₹1.32 Cr (FY 2025)Active

Board colleagues of Dharmendra Singh

Directorship timeline

Open interactive timeline →
Orb Pharma Private Limited
Premium access

Shareholding and investment profile for Dharmendra Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dharmendra Singh

Dharmendra Singh currently holds 1 directorship: Orb Pharma Private Limited (Director, since 28 Feb 2019, revenue ₹1.32 Cr (FY 2025)).

Dharmendra Singh was first appointed on 28 Feb 2019 as Director at Orb Pharma Private Limited.

The current boards of Dharmendra Singh's companies include Jai Prakash Narayan Singh (Orb Pharma Private Limited), Ranjeet Kumar (Orb Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available